Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR using fluorescently labeled probes

Leukemia and Lymphoma

Volumn 42, Issue 4, 2001, Pages 747-756

  Barragan E ^a   Bolufer, P ^a   Moreno, I ^a   Martin G ^a   Nomdedeu, J ^a   Brunet, S ^a   Fernandez P ^a   Rivas, C ^a   Sanz, M A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acute myeloid leukemia; AML1 ETO; Minimal residual disease; Quantitative PCR; Real time PCR

Indexed keywords

COMPLEMENTARY DNA; FLUORESCENT DYE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; APHERESIS; ARTICLE; BONE MARROW; CANCER RECURRENCE; CHEMICAL LABELING; CHILD; CHROMOSOME 21Q; CHROMOSOME 8Q; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; EQUIPMENT; FEMALE; FOLLOW UP; GENE FUSION; GENE REARRANGEMENT; HEMATOLOGY; HUMAN; HYBRIDIZATION; LEUKEMIA REMISSION; MALE; MINIMAL RESIDUAL DISEASE; MONITORING; PRIORITY JOURNAL; REGRESSION ANALYSIS; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; SENSITIVITY AND SPECIFICITY; TECHNIQUE; TECHNOLOGY; TUBE;

EID: 0034866323     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109099337     Document Type: Article

References (20)

1. Cytogenetics and their prognostic significance in acute myeloid leuka: A report on 283 cases
2. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1612 patients entered into the MRC AML 10 Trial
3. 8;21 translocation in acute granulocytic leukaemia: Cytological, cytochemical and clinical features
4. Identification of breakpoints in t(8;21) acute myelogenous leukaemia and isolation of a fusion transcript AML1/ETO with similarity to Drosophila segmentation gene, runt
5. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
6. Translocation breakpoints are clustered on both chromosome 8 and chromosome 21 in the t(8;21) of acute myeloid leukemia
7. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction
8. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the t(8;21) (q22;q22) translocation
9. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission
10. Persistence of the AML1/ETO fusion transcript in patients treated with allogenic bone marrow transplantation for t(8;21) leukemia
11. Serial quantification of minimal residual disease of t(8;21) acute myelogenous leukemia with RT-competitive PCR assay
12. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia
13. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction
14. Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia
15. Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia
16. Zwischenmoleculare Energiewanderung und Fluorescenz
17. Single-step method of RNA isolation by acid guanidinium-thiocyanate phenol-chloroform extraction
18. Disappearance of AML1-MTG8 (ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission
19. Real time quantitative PCR
20. Kinetic PCR analysis: Real-time monitoring of DNA amplification reaction